Nadroparin calcium
Nadroparin Calcium
Nadroparin calcium (pronunciation: na-dro-par-in cal-cium) is a type of anticoagulant medication, specifically a low molecular weight heparin (LMWH). It is used to prevent and treat blood clots in the veins, a condition known as venous thromboembolism.
Etymology
The term "Nadroparin" is derived from the name of the pharmaceutical company that first developed it, Sanofi-Aventis. "Calcium" refers to the calcium salt form of the drug, which is used to enhance its stability and bioavailability.
Usage
Nadroparin calcium is used in the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used to prevent clotting in the extracorporeal circulation during hemodialysis.
Mechanism of Action
Nadroparin calcium works by inhibiting the activity of certain clotting factors in the blood, specifically factor Xa and factor IIa. This prevents the formation of fibrin, the protein that binds blood cells together to form clots.
Related Terms
- Anticoagulant
- Low molecular weight heparin
- Venous thromboembolism
- Deep vein thrombosis
- Pulmonary embolism
- Hemodialysis
- Factor Xa
- Factor IIa
- Fibrin
External links
- Medical encyclopedia article on Nadroparin calcium
- Wikipedia's article - Nadroparin calcium
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski